Align technology announces second quarter 2025 financial results

Tempe, ariz.--(business wire)--align technology, inc. (nasdaq: algn), a leading global medical device company that designs, manufactures, and sells the invisalign® system of clear aligners, itero™ intraoral scanners, and exocad™ cad/cam software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter ("q2'25"). q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year. q2'25 total revenues were favorably imp.
ALGN Ratings Summary
ALGN Quant Ranking